Citation Impact
Citing Papers
Phenotypic and functional features of human Th17 cells
2007 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract
2004 Standout
Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010
2013 Standout
Open label trial of anakinra in active ankylosing spondylitis over 24 weeks
2004
Genetic studies in familial ankylosing spondylitis susceptibility
2004
Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial
2006 Standout
Imbalance in distribution of functional autologous regulatory T cells in rheumatoid arthritis
2007
Early referral recommendations for ankylosing spondylitis (including pre-radiographic and radiographic forms) in primary care
2004
The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells
2006 Standout
The anatomical basis of intestinal immunity
1997
Interferons as pathogenic effectors in autoimmunity
2005
The SKG model of spondyloarthritis
2017
Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: Evaluation of a new scoring system
2003
Immunohistochemical analysis of hip arthritis in ankylosing spondylitis: Evaluation of the bone–cartilage interface and subchondral bone marrow
2006
Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo‐controlled trial (ASSERT)
2005
Interleukin-17 Family Members and Inflammation
2004 Standout
Rheumatoid arthritis
2016 Standout
Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional x rays with magnetic resonance imaging using established and new scoring systems
2004
Th1/Th2 Cells
1999
Ido expression by dendritic cells: tolerance and tryptophan catabolism
2004 Standout
Can we induce tolerance in rheumatoid arthritis?
2001
Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor α blockers in ankylosing spondylitis
2004
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity
2007 StandoutNobel
Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society
2007 Standout
Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor α in two patients with early disease and transforming growth factor β in three more advanced cases
2005
Inflammatory back pain in ankylosing spondylitis: A reassessment of the clinical history for application as classification and diagnostic criteria
2006
Animal models of inflammatory spinal and sacroiliac joint diseases
2003
Juvenile idiopathic arthritis
2007 Standout
Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes
2007
T cell epitope–specific immune therapy for rheumatic diseases
2005
Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis— cellularity correlates with the degree of enhancement detected by magnetic resonance imaging
2000
Infliximab improves productivity and reduces workday loss in patients with ankylosing spondylitis: Results from a randomized, placebo‐controlled trial
2006
Enthesitis and ankylosis in spondyloarthropathy: What is the target of the immune response?
2000
Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: Clinical and magnetic resonance imaging data
2005
Anti-TNF-alpha therapy in ankylosing spondylitis
2006
Conventional treatments for ankylosing spondylitis
2002
Mucosal immunity and vaccines
2005 Standout
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double‐blind, placebo‐controlled trial
2006
Osteoarthritis
2015 Standout
ASAS/EULAR recommendations for the management of ankylosing spondylitis
2005
WNT signaling in bone homeostasis and disease: from human mutations to treatments
2013 Standout
Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis
2001 Standout
Pathogenesis of spondylarthropathies
1995
Evolving concepts of rheumatoid arthritis
2003 StandoutNature
Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis
2000
Interleukin-17 and Type 17 Helper T Cells
2009 Standout
Anti–tumor necrosis factor α blockade in the treatment of juvenile spondylarthropathy
2005
Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis
2004
Six months open label trial of leflunomide in active ankylosing spondylitis
2004
Ankylosing spondylitis
2007 Standout
First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis
2005
IL-12-and IL-23 in health and disease
2014
International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis
2003
PROGNOSIS, COURSE OF DISEASE, AND TREATMENT OF THE SPONDYLOARTHROPATHIES
1998
Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial
2002 Standout
Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor α receptor fusion protein etanercept
2005
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
2005 Standout
The Biological Functions of T Helper 17 Cell Effector Cytokines in Inflammation
2008 Standout
How to diagnose axial spondyloarthritis early
2004
Rheumatic diseases: the effects of inflammation on bone
2005
Predominant cellular immune response to the cartilage autoantigenic G1 aggrecan in ankylosing spondylitis and rheumatoid arthritis
2003
HLA–B27–restricted CD8+ T cell response to cartilage‐derived self peptides in ankylosing spondylitis
2005
Interleukin-23 Promotes a Distinct CD4 T Cell Activation State Characterized by the Production of Interleukin-17
2003 Standout
Idiopathic Pulmonary Fibrosis
2001 Standout
The juvenile-onset spondyloarthritides
2002
The burden of ankylosing spondylitis and the cost-effectiveness of treatment with infliximab (Remicade(R))
2004
Successful treatment of active ankylosing spondylitis with the anti–tumor necrosis factor α monoclonal antibody infliximab
2000
Multiple Sclerosis
2000 Standout
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part II
2007 Standout
Juvenile-onset ankylosing spondylitis is associated with worse functional outcomes than adult-onset ankylosing spondylitis
2005
Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-? antagonists
2007
Cytokine gene polymorphisms relevant for the spondyloarthropathies
2001
Adalimumab reduces spinal symptoms in active ankylosing spondylitis: Clinical and magnetic resonance imaging results of a fifty‐two–week open‐label trial
2006
Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumour necrosis factor α antibody infliximab
2005
Persistent clinical response to the anti-TNF-α antibody infliximab in patients with ankylosing spondylitis over 3 years
2005
Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival
2001 Standout
Elucidation of Lyme arthritis
2004
ANKYLOSING SPONDYLITIS
1998
Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial
2003
Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis
2004
Radiographic assessment of sacroiliitis by radiologists and rheumatologists: does training improve quality?
2003
Analysis of the CD8+ T cell response to the G1 domain of aggrecan in ankylosing spondylitis
2004
Treatment of Ankylosing Spondylitis by Inhibition of Tumor Necrosis Factor α
2002
Lyme borreliosis
2011 Standout
Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after 2 yrs of treatment with the anti-tumour necrosis factor agent infliximab
2005
Blockade of Dickkopf (DKK)-1 induces fusion of sacroiliac joints
2009
Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: Results of a multicenter, randomized, double‐blind, placebo‐controlled magnetic resonance imaging study
2006
Inferences, questions and possibilities in Toll-like receptor signalling
2004 StandoutNatureNobel
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
RADIOLOGIC DIAGNOSIS AND PATHOLOGY OF THE SPONDYLOARTHROPATHIES
1998
Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab
2005
Multiple sclerosis
2002 Standout
The challenge of diagnosis and classification in early ankylosing spondylitis: Do we need new criteria?
2005 Standout
Interleukin-13 Induces Tissue Fibrosis by Selectively Stimulating and Activating Transforming Growth Factor β1
2001 Standout
Recombination in theompAGene but Not theomcBGene ofChlamydiaContributes to Serovar-Specific Differences in Tissue Tropism, Immune Surveillance, and Persistence of the Organism
2001
T‐cell receptor signaling and the pathogenesis of autoimmune arthritis: insights from mouse and man
2012 StandoutNobel
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
2005 Standout
Eta-1 (Osteopontin): An Early Component of Type-1 (Cell-Mediated) Immunity
2000 Science
The extracellular matrix: A dynamic niche in cancer progression
2012 Standout
Safety and efficacy of readministration of infliximab after longterm continuous therapy and withdrawal in patients with ankylosing spondylitis.
2007
Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria
2001 Standout
Prevalence of rheumatic symptoms, rheumatoid arthritis, ankylosing spondylitis, and gout in Shanghai, China: a COPCORD study.
2003
IL-17 and Th17 Cells
2009 Standout
The immunologic homunculus in rheumatoid arthritis
1999
Network of dendritic cells within the muscular layer of the mouse intestine
2005 StandoutNobel
Microbial Lipopeptides Induce the Production of IL-17 in Th Cells
2000
CpG Motifs in Bacterial DNA and Their Immune Effects
2002 Standout
Update on Spondyloarthropathies
2002
IMMUNOLOGY OF MULTIPLE SCLEROSIS
2005 Standout
Chromosomal DNA from a variety of bacterial species is present in synovial tissue from patients with various forms of arthritis
2001
Bone loss is detected more frequently in patients with ankylosing spondylitis with syndesmophytes.
2005
Knee osteoarthritis has doubled in prevalence since the mid-20th century
2017 Standout
TRACP Influences Th1 Pathways by Affecting Dendritic Cell Function
2006 StandoutNobel
Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis
1999
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
Regulation and Role of IFN-γ in the Innate Resistance to Infection withChlamydia pneumoniae
2000
Th1/Th2 cells
2007
On the conservative nature of intragenic recombination
2005 StandoutNobel
Functional deficiencies of granulocyte-macrophage colony stimulating factor and interleukin-3 contribute to insulitis and destruction of β cells
2007 StandoutNobel
ORAL TOLERANCE FOR THE TREATMENT OF AUTOIMMUNE DISEASES
1997
TNF‐mediated inflammatory disease
2007 Standout
The role of T cells in the immunopathogenesis of rheumatoid arthritis. New perspectives
1997
Impaired T cell receptor signaling and development of T cell–mediated autoimmune arthritis
2020 StandoutNobel
Works of U. Eggens being referenced
The elevated ratio of interferon gamma-/ interleukin-4-positive T cells found in synovial fluid and synovial membrane of rheumatoid arthritis patients can be changed by interleukin-4 but not by interleukin-10 or transforming growth factor beta
1999
Oral type II collagen treatment in early rheumatoid arthritis. A double‐blind, placebo‐controlled, randomized trial
1996
Crucial role of interleukin‐10/interleukin‐12 balance in the regulation of the type 2 T helper cytokine response in reactive arthritis
1997
T cell cytokine pattern in the joints of patients with lyme arthritis and its regulation by cytokines and anticytokines
1997
No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: A three-month, multicenter, double-blind, randomized, placebo-controlled study
1999
Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis
1995
Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients
1994
Early sacroiliitis in patients with spondyloarthropathy: evaluation with dynamic gadolinium-enhanced MR imaging.
1995
Studying patients with inflammatory back pain and arthritis of the lower limbs clinically and by magnetic resonance imaging: many, but not all patients with sacroiliitis have spondyloarthropathy
1999
Computed tomography guided corticosteroid injection of the sacroiliac joint in patients with spondyloarthropathy with sacroiliitis: clinical outcome and followup by dynamic magnetic resonance imaging.
1996
Nested polymerase chain reaction strategy simultaneously targeting DNA sequences of multiple bacterial species in inflammatory joint diseases. I. Screening of synovial fluid samples of patients with spondyloarthropathies and other arthritides.
1997
Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors
1998
Chlamydia pneumoniae–a new causative agent of reactive arthritis and undifferentiated oligoarthritis.
1994
Increased frequency of Sjögren's syndrome in patients with spondyloarthropathy.
1998
Nested polymerase chain reaction strategy simultaneously targeting DNA sequences of multiple bacterial species in inflammatory joint diseases. II. Examination of sacroiliac and knee joint biopsies of patients with spondyloarthropathies and other arthritides.
1997
Prevalence of spondylarthropathies in HLA‐B27 positive and negative blood donors
1998